Please wait a minute...
Search Asian J Urol Advanced Search
Share 
Asian Journal of Urology, 2023, 10(2): 128-136    doi: 10.1016/j.ajur.2021.10.004
  本期目录 | 过刊浏览 | 高级检索 |
Robotic approach with neoadjuvant chemotherapy in adult Wilms’ tumor: A feasibility study report and a systematic review of the literature
Simone Sforzaab*(),Valeria Emma Palmieric,Maria Rosaria Raspollinid,Giandomenico Rovielloc,Alberto Mantovanib,Umberto Bassoe,Maria Carmen Affinitaf,Alberto D’Angelog,Lorenzo Antonuzzoc,Marco Carinia,Andrea Minervinia,Lorenzo Masieriab
aDepartment of Oncologic, Minimally-Invasive Urology and Andrology, Careggi Hospital, University of Florence, Florence, Italy
bDepartment of Pediatric Urology, Meyer Children Hospital, University of Florence, Florence, Italy
cClinical Oncologic Unit, Careggi Hospital, University of Florence, Florence, Italy
dHistopathology and Molecular Diagnostics, Careggi Hospital, University of Florence, Florence, Italy
eMedical Oncology Unit 1, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy
fHematology Oncology Division, Department of Women’s and Children’s Health, Padova University Hospital, Padua, Italy
gDepartment of Biology and Biochemistry, University of Bath, Bath, UK
下载:  HTML  PDF (5333KB) 
输出:  BibTeX | EndNote (RIS)      
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
Abstract: 

Objective: The incidence of Wilms’ tumor (WT) among adult individuals accounts for less than 1% of kidney cancer cases, with a prognosis usually less favorable when compared to younger individuals and an overall survival rate of 70% for the adult patients versus 90% for the pediatric cases. The diagnosis and treatment of WT are complex in the preoperative setting; neoadjuvant chemotherapy (NAC) or robotic surgery has rarely been described. This study aimed to review the literature of robotic surgery in WT and report the first adult WT management using both NAC and robotic strategy.
Methods: We reported a case of WT managed in a multidisciplinary setting. Furthermore, according to Preferred Reporting Items for Systematic reviews and Meta-Analyses recommendations, a systematic review of the literature until August 2020 of WT treated with a robotic approach was carried out.
Results: A 33-year-old female had a diagnosis of WT. She was scheduled to NAC, and according to the clinical and radiological response to a robotic radical nephrectomy with aortic lymph nodes dissection, she was managed with no intraoperative rupture, a favorable surgical outcome, and a follow-up of 25 months, which did not show any recurrence. The systematic review identified a total number of 230 cases of minimally invasive surgery reported in the literature for WT. Of these, approximately 15 patients were carried out using robotic surgery in adolescents while none in adults. Moreover, NAC has not been administered before minimally invasive surgery in adults up until now.
Conclusion: WT is a rare condition in adults with only a few cases treated with either NAC or minimally invasive approach so far. The advantage of NAC followed by the robotic approach could lead to favorable outcomes in this complex scenario. Notwithstanding, additional cases of adult WT need to be identified and investigated to improve the oncological outcome.

Key words:  Nephroblastoma    Nephrectomy    Renal neoplasm    Minimally invasive surgery    Rare tumor    Wilms' tumor
收稿日期:  2020-08-20      修回日期:  2021-06-04      接受日期:  2021-10-13      出版日期:  2023-04-20      发布日期:  2023-05-24      整期出版日期:  2023-04-20
引用本文:    
. [J]. Asian Journal of Urology, 2023, 10(2): 128-136.
Simone Sforza,Valeria Emma Palmieri,Maria Rosaria Raspollini,Giandomenico Roviello,Alberto Mantovani,Umberto Basso,Maria Carmen Affinita,Alberto D’Angelo,Lorenzo Antonuzzo,Marco Carini,Andrea Minervini,Lorenzo Masieri. Robotic approach with neoadjuvant chemotherapy in adult Wilms’ tumor: A feasibility study report and a systematic review of the literature. Asian Journal of Urology, 2023, 10(2): 128-136.
链接本文:  
http://www.ajurology.com/CN/10.1016/j.ajur.2021.10.004  或          http://www.ajurology.com/CN/Y2023/V10/I2/128
  
  
  
  
  
Authors, year of publication; type of study design Patient, n Sex Age, year NAC Type of surgery; operative time, min Estimated blood loss, mL; complication Length of hospital stay, day Positive surgical margin; lymph node (retrieval number) Follow-up, month Local recurrence; overall survival
Cost et al., 2015, [18]; case report 1 Female 14.0 No -RN; 210 NR; none 2 No; NR NR NR
Meignan et al., 2018, [19]; retrospective study 1 Female 3.6 Yes -RN; 263 <5; none 4 No; NR 84 No; 100.0%
Yadav et al., 2018, [20]; case report 1 Female 1.5 Yes -PN; NR NR; persistent output from drain (28 days) 28 No; none NR NR
Blanc et al., 2019, [11]; prospective study 8 NR Mean: 5.0 (range 3.2-10.1) Yes -6 RN; mean: 245 (range 120-360)
-2 PN; 120 and 110
NR; two conversion to open surgery Median: 4 (range 2-7) No; median: 6 (range 2-10) Median: 14.8 (range 4.0-25.0) No; 87.5%
Sala et al., 2020, [21]; case report 1 Male 3.0 Yes -RN and PN (bilateral procedure); 90 50; none 2 NR; none NR NR
  
[1] Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277-300.
doi: 10.3322/caac.20073
[2] Cunningham ME, Klug TD, Nuchtern JG, Chintagumpala MM, Venkatramani R, Lubega J, et al. Global disparities in Wilms tumor. J Surg Res 2020; 247:34-51.
doi: S0022-4804(19)30774-7 pmid: 31810638
[3] Coorens THH, Treger TD, Al-Saadi R, Moore L, Tran MGB, Mitchell TJ, et al. Embryonal precursors of Wilms tumor. Science 2019; 366:1247-51.
doi: 10.1126/science.aax1323 pmid: 31806814
[4] Reinhard H, Aliani S, Ruebe C, St?ckle M, Leuschner I, Graf N. Wilms’ tumor in adults: results of the society of pediatric Oncology (SIOP) 93-01/society for pediatric Oncology and hematology (GPOH) study. J Clin Oncol 2004; 22:4500-6.
doi: 10.1200/JCO.2004.12.099 pmid: 15542800
[5] Izawa JI, Al-Omar M, Winquist E, Stitt L, Rodrigues G, Steele S, et al. Prognostic variables in adult Wilms tumour. Can J Surg 2008; 51:252-6.
pmid: 18815646
[6] de Kraker J, Graf N, van Tinteren H, Pein F, Sandstedt B, Godzinski J, et al. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms’ tumour (SIOP 93-01 trial): a randomised controlled trial. Lancet 2004; 364:1229-35.
doi: 10.1016/S0140-6736(04)17139-0 pmid: 15464183
[7] Pritchard-Jones K, Bergeron C, De Camargo B, Van Den Heuvel-Eibrink MM, Acha T, Godzinski J, et al. Omission of doxorubicin from the treatment of stage IIeIII, intermediate-risk Wilms’ tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. Lancet 2015; 386:1156-64.
doi: 10.1016/S0140-6736(14)62395-3 pmid: 26164096
[8] Ali AN, Diaz R, Shu H-K, Paulino AC, Esiashvili N. A Surveillance, Epidemiology and End Results (SEER) program comparison of adult and pediatric Wilms’ tumor. Cancer 2012; 118: 2541-51.
doi: 10.1002/cncr.26554
[9] Spreafico F, Ferrari A, Mascarin M, Collini P, Morosi C, Biasoni D, et al. Wilms tumor, medulloblastoma, and rhabdomyosarcoma in adult patients: lessons learned from the pediatric experience. Cancer Metastasis Rev 2019; 38:683-94.
doi: 10.1007/s10555-019-09831-3
[10] Bouty A, Burnand K, Nightingale M, Roberts A, Campbell M, O’Brien M, et al. What is the risk of local recurrence after laparoscopic transperitoneal radical nephrectomy in children with Wilms tumours? Analysis of a local series and review of the literature. J Pediatr Urol 2018; 14:327.e1-7. https://doi.org/10.1016/j.jpurol.2018.03.016.
doi: 10.1016/j.jpurol.2018.03.016
[11] Blanc T, Pio L, Clermidi P, Muller C, Orbach D, Minard-Colin V, et al. Robotic-assisted laparoscopic management of renal tumors in children: preliminary results. Pediatr Blood Cancer 2019; 66:1-7.
[12] Terenziani M, Spreafico F, Collini P, Piva L, Perotti D, Podda M, et al. Adult Wilms’ tumor: a monoinstitutional experience and a review of the literature. Cancer 2004; 101:289-93.
doi: 10.1002/cncr.20387 pmid: 15241825
[13] Liberati A, Altman DG, Tetzlaff J, Mulrow C, G?tzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339:b2700. https://doi.org/10.1136/bmj.b2700.
doi: 10.1136/bmj.b2700
[14] Sforza S, Di Maida F, Mari A, Zaccaro C, Cini C, Tellini R, et al. Is a drainage placement still necessary after robotic reconstruction of the upper urinary tract in children? Experience from a tertiary referral center. J Laparoendosc Adv Surg Tech 2019; 29:1180-4.
doi: 10.1089/lap.2019.0302
[15] Masieri L, Sforza S, Grosso AA, Cini C, Viola L, Tellini R, et al. Does the body weight influence the outcome in children treated with robotic pyeloplasty? J Pediatr Urol 2020; 16: 109.e1-6. https://doi.org/10.1016/j.jpurol.2019.10.023.
doi: 10.1016/j.jpurol.2019.10.023
[16] Sforza S, Minervini A, Tellini R, Ji C, Bergamini C, Giordano A, et al. Perioperative outcomes of robotic and laparoscopic adrenalectomy: a large international multicenter experience. Surg Endosc 2021; 35:1801-7.
doi: 10.1007/s00464-020-07578-5
[17] Kieran K, Ehrlich PF. Current surgical standards of care in Wilms tumor. Urol Oncol Semin Orig Investig 2016; 34:13-23.
[18] Cost NG, Liss ZJ, Bean CM, Geller JI, Minevich EA, Noh PH. Prechemotherapy robotic-assisted laparoscopic radical nephrectomy for an adolescent with wilms tumor. J Pediatr Hematol Oncol 2015; 37:e125-7. https://doi.org/10.1097/MPH.0000000000000193.
doi: 10.1097/MPH.0000000000000193
[19] Meignan P, Ballouhey Q, Lejeune J, Braik K, Longis B, Cook AR, et al. Robotic-assisted laparoscopic surgery for pediatric tumors: a bicenter experience. J Robot Surg 2018; 12:501-8.
doi: 10.1007/s11701-017-0773-2 pmid: 29288372
[20] Yadav P, Mahajan A, Kandpal DK, Chowdhary SK. Nephronsparing surgery for syndromic Wilms’ tumor: robotic approach. Urology 2018; 116:172-5.
doi: 10.1016/j.urology.2018.03.003
[21] Sala LFM, Guglielmetti GB, Coelho RF. Bilateral nephrectomy robotic-assisted laparoscopic in children with bilateral Wilms’ tumor. Urol Case Reports 2020; 31:101146. https://doi.org/10.1016/j.eucr.2020.101146.
[22] Fukuzawa H, Shiima Y, Mishima Y, Sekine S, Miura S, Yabe K, et al. Predictive factor for intraoperative tumor rupture of Wilms tumor. Pediatr Surg Int 2017; 33:91-5.
doi: 10.1007/s00383-016-4000-4 pmid: 27803953
[23] Gandaglia G, Bravi CA, Dell’Oglio P, Mazzone E, Fossati N, Scuderi S, et al. The Impact of Implementation of the European Association of Urology guidelines panel recommendations on reporting and grading complications on perioperative outcomes after robot-assisted radical prostatectomy. Eur Urol 2018; 74:4-7.
doi: S0302-2838(18)30175-1 pmid: 29544735
[24] Masieri L, Sforza S, Cini C, Escolino M, Grosso A, Esposito C, et al. Minilaparoscopic versus open pyeloplasty. J Laparoendosc Adv Surg Tech 2019; 29:1-6.
doi: 10.1089/lap.2018.0124
[25] Hussein AA, Elsayed AS, Aldhaam NA, Jing Z, Osei J, Kaouk J, et al. Ten-year oncologic outcomes following robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. J Urol 2019; 202:927-35.
doi: 10.1097/JU.0000000000000386 pmid: 31188729
[26] Bouty A, Blanc T, Leclair MD, Lavrand F, Faure A, Binet A, et al. Minimally invasive surgery for unilateral Wilms tumors: multicenter retrospective analysis of 50 transperitoneal laparoscopic total nephrectomies. Pediatr Blood Cancer 2020; 67:e28212. https://doi.org/10.1002/pbc.28212.
[27] Scuderi MG, Di Cataldo A, Fusco M, Betta P, Spampinato G, Arena S, et al. Laparoscopic nephrectomy in children with Wilms tumor. Considerations after 10 years of experience. J Biol Regul Homeost Agents 2019; 33:95-103.
[28] Zakaria OM, Daoud MYI, Sultan TA, El Sayem K, Zakaria HM, El-Gibaly AM, et al. Laparoscopy as a primary investigatory tool in pediatric abdominal masses. Gulf J Oncolog 2018; 1:52-5.
pmid: 30344135
[29] Flores P, Cadario M, Lenz Y, Cacciavillano W, Galluzzo L, Nestor Paz EG, et al. Laparoscopic total nephrectomy for Wilms tumor: towards new standards of care. J Pediatr Urol 2018; 14:388-93.
doi: S1477-5131(18)30349-8 pmid: 30049484
[30] Brown JT, Harik LR, Barbee MS, Esiashvili N, Badell ML, Goldsmith KC, et al. Multidisciplinary care of adult Wilms’ tumor during pregnancy: a case report and review of the literature. Clin Genitourin Cancer 2020; 18:e1-4. https://doi.org/10.1016/j.clgc.2019.09.021.
[31] de Vries-Brilland M, Sionneau B, Dutriaux C, Blay JY, Ravaud A, Gross-Goupil M. Successful treatment of metastatic adult Wilms tumor with anti-BRAF treatment: a case report and a brief review of the literature. Clin Genitourin Cancer 2019; 17: e721-3. https://doi.org/10.1016/j.clgc.2019.02.012.
[32] Bradtke M, Rink M, Büscheck F, Sauter G, Dahlem R, Fisch M, et al. Current therapies of Wilms tumors in the adult: diagnostic considerations and treatment challenges. Clin Genitourin Cancer 2019; 17:e522-5. https://doi.org/10.1016/j.clgc.2019.01.016.
doi: 10.1016/j.clgc.2019.01.016
[33] Marconi L, Dabestani S, Lam TB, Hofmann F, Stewart F, Norrie J, et al. Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol 2016; 69:660-73.
doi: S0302-2838(15)00741-1 pmid: 26323946
[34] Sanchez A, Feldman AS, Ari Hakimi A. Current management of small renal masses, including patient selection, renal tumor biopsy, active surveillance, and thermal ablation. J Clin Oncol 2018. https://doi.org/10.1200/JCO.2018.79.2341.
[35] Segers H, Van Den Heuvel-Eibrink MM, Pritchard-Jones K. Management of adults with Wilms’ tumor: recommendations based on international consensus. Expert Rev Anticancer Ther 2011; 11:1107-15.
doi: 10.1586/era.11.76
[36] Kattan J, Tournade MF, Culine S, Terrier-Lacombe MJ, Droz JP. Adult Wilms’ tumour: review of 22 cases. Eur J Cancer 1994; 30A:1778-82. https://doi.org/10.1016/0959-8049(94)00315-v.
pmid: 7880605
[37] Kalapurakal JA, Nan B, Norkool P, Coppes M, Perlman E, Beckwith B, et al. Treatment outcomes in adults with favorable histologic type Wilms tumordan update from the National Wilms Tumor Study Group. Int J Radiat Oncol Biol Phys 2004; 60:1379-84.
doi: 10.1016/j.ijrobp.2004.05.057
[38] Oostveen RM, Pritchard-Jones K. Pharmacotherapeutic management of Wilms tumor: an update. Paediatr Drugs 2019; 21: 1-13.
doi: 10.1007/s40272-018-0323-z pmid: 30604241
[39] Vujani? GM, Sandstedt B, Kelsey A, Sebire NJ. Central pathology review in multicenter trials and studies: lessons from the nephroblastoma trials. Cancer 2009; 115:1977-83.
doi: 10.1002/cncr.24214 pmid: 19241454
[40] Shah SH, Movassaghi K, Skinner D, Dalag L, Miranda G, Cai J, et al. Ureteroenteric strictures after open radical cystectomy and urinary diversion: the University of Southern California experience. Urology 2015; 86:87-91.
doi: 10.1016/j.urology.2015.03.014 pmid: 25987494
[41] Masieri L, Sforza S, Di Maida F, Grosso AA, Mari A, Rosi EM, et al. Robotic correction of iatrogenic ureteral stricture: preliminary experience from a tertiary referral centre. Scand J Urol 2019; 53:356-60.
doi: 10.1080/21681805.2019.1651390 pmid: 31469016
[42] Mari A, Sforza S, Morselli S, Campi R, Masieri L, Carini M, et al. Surgical outcome of 100 consecutive robot-assisted pyeloplasty cases with no drainage placement for ureteropelvic junction obstruction. Int J Urol 2018; 25:700-1.
doi: 10.1111/iju.13700 pmid: 29855093
[43] Good DW, Stewart GD, Ju Stolzenburg, McNeill SA. Analysis of the pentafecta learning curve for laparoscopic radical prostatectomy. World J Urol 2014; 32:1225-33.
doi: 10.1007/s00345-013-1198-9 pmid: 24326782
[44] Warmann SW, Godzinski J, van Tinteren H, Heij H, Powis M, Sandstedt B, et al. Minimally invasive nephrectomy for Wilms tumors in childrenddata from SIOP 2001. J Pediatr Surg 2014; 49:1544-8.
doi: 10.1016/j.jpedsurg.2014.06.005 pmid: 25475791
[45] Stewart CL, Bruny JL. Maximizing lymph node retrieval during surgical resection of Wilms tumor. Eur J Pediatr Surg 2015; 25: 109-12.
doi: 10.1055/s-0034-1386637 pmid: 25111272
[46] Vujani? GM, Gessler M, Ooms AHAG, Collini P, Coulombl’Hermine A, D’Hooghe E, et al. The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol. Nat Rev Urol 2018; 15:693-701.
doi: 10.1038/s41585-018-0100-3 pmid: 30310143
[47] Saltzman AF, Smith DE, Gao D, Ghosh D, Amini A, Aldrink JH, et al. How many lymph nodes are enough? Assessing the adequacy of lymph node yield for staging in favorable histology wilms tumor. J Pediatr Surg 2019; 54:2331-5.
doi: S0022-3468(19)30407-5 pmid: 31255328
[48] Duarte RJ, Dénes FT, Cristofani LM, Odone-Filho V, Srougi M. Further experience with laparoscopic nephrectomy for Wilms’ tumour after chemotherapy. BJU Int 2006; 98:155-9.
doi: 10.1111/bju.2006.98.issue-1
[49] Murphy AJ, Davidoff AM. Bilateral Wilms tumor: a surgical perspective. Child (Basel, Switzerland) 2018; 5:134. https://doi.org/10.3390/children5100134.
[50] Davidoff AM, Giel DW, Jones DP, Jenkins JJ, Krasin MJ, Hoffer FA, et al. The feasibility and outcome of nephron-sparing surgery for children with bilateral Wilms tumor. The St Jude Children’s Research Hospital experience: 1999-2006. Cancer 2008; 112:2060-70. https://doi.org/10.1002/cncr.23406.
doi: 10.1002/cncr.23406 pmid: 18361398
[51] Richards MK, Goldin AB, Ehrlich PF, Beierle EA, Doski JJ, Goldfarb M, et al. Partial nephrectomy for nephroblastoma: a national cancer data base review. Am Surg 2018; 84:338-43.
pmid: 29559046
[52] Han Q, Li K, Dong K, Xiao X, Yao W, Liu G. Clinical features, treatment, and outcomes of bilateral Wilms’ tumor: a systematic review and meta-analysis. J Pediatr Surg 2018; 53:2465-9.
doi: 10.1016/j.jpedsurg.2018.08.022
No related articles found!
[1] Allen C. Gao,James L. Mohler. In honor of Dr. Donald S. Coffey - Prostate cancer biology and therapy[J]. Asian Journal of Urology, 2019, 6(1): 1 -2 .
[2] Karen S. Sfanos,Srinivasan Yegnasubramanian,William G. Nelson,Tamara L. Lotan,Ibrahim Kulac,Jessica L. Hicks,Qizhi Zheng,Charles J. Bieberich,Michael C. Haffner,Angelo M. De Marzo. If this is true, what does it imply? How end-user antibody validation facilitates insights into biology and disease[J]. Asian Journal of Urology, 2019, 6(1): 10 -25 .
[3] Pei Zhao,Yezi Zhu,Liang Cheng,Jun Luo. Detection of androgen receptor (AR) and AR-V7 in small cell prostate carcinoma: Diagnostic and therapeutic implications[J]. Asian Journal of Urology, 2019, 6(1): 109 -113 .
[4] Liqun Zhou,Kaiwei Yang,Xuesong Li,Yi Ding,Dawei Mu,Hanzhong Li,Yong Yan,Jinyi Li,Dongwen Wang,Wei Li,Yulong Cong,Jiangping Gao,Kewei Ma,Yajun Xiao,Sheng Zhang,Hongyi Jiang,Weilie Hu,Qiang Wei,Xunbo Jin,Zhichen Guan,Qingyong Liu,Danfeng Xu,Xin Gao,Yongguang Jiang,Weimin Gan,Guang Sun,Qing Wang,Yanhui Liu,Jianquan Hou,Liping Xie,Xishuang Song,Fengshuo Jin,Jiafu Feng,Ming Cai,Zhaozhao Liang,Jie Zhang,Dingwei Ye,Lin Qi,Lulin Ma,Jianzhong Shou,Yuping Dai,Jianyong Shao,Ye Tian,Shizhe Hong,Tao Xu,Chuize Kong,Zefeng Kang,Yuexin Liu,Xun Qu,Benkang Shi,Shaobin Zheng,Yi Lin,Shujie Xia,Dong Wei,Jianbo Wu,Weiling Fu,Zhiping Wang,Jianbo Liang. Application of fluorescence in situ hybridization in the detection of bladder transitional-cell carcinoma: A multi-center clinical study based on Chinese population(☆ Hospitals 1 and 3w53 were all in the study group of Fluorescence in situ hybridization in prenatal genetic diseases and cancer detection in clinical research of Chinese population.)[J]. Asian Journal of Urology, 2019, 6(1): 114 -121 .
[5] Liang Dong,Richard C. Zieren,Wei Xue,Theo M. de Reijke,Kenneth J. Pienta. Metastatic prostate cancer remains incurable, why?[J]. Asian Journal of Urology, 2019, 6(1): 26 -41 .
[6] William B. Isaacs,Jianfeng Xu. Current progress and questions in germline genetics of prostate cancer[J]. Asian Journal of Urology, 2019, 6(1): 3 -9 .
[7] Cameron M. Armstrong,Allen C. Gao. Current strategies for targeting the activity of androgen receptor variants[J]. Asian Journal of Urology, 2019, 6(1): 42 -49 .
[8] Michael V. Fiandalo,Daniel T. Gewirth,James L. Mohler. Potential impact of combined inhibition of 3α-oxidoreductases and 5α-reductases on prostate cancer[J]. Asian Journal of Urology, 2019, 6(1): 50 -56 .
[9] Tyler Etheridge,Shivashankar Damodaran,Adam Schultz,Kyle A. Richards,Joseph Gawdzik,Bing Yang,Vincent Cryns,David F. Jarrard. Combination therapy with androgen deprivation for hormone sensitive prostate cancer: A new frontier[J]. Asian Journal of Urology, 2019, 6(1): 57 -64 .
[10] Gina Chia-Yi Chu,Leland W.K. Chung,Murali Gururajan,Chia-Ling Hsieh,Sajni Josson,Srinivas Nandana,Shian-Ying Sung,Ruoxiang Wang,Jason Boyang Wu,Haiyen E. Zhau. Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics[J]. Asian Journal of Urology, 2019, 6(1): 65 -81 .
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed